Loading…
Loading…
Loading…
Co-therapy comprising a small molecule CSF-1R inhibitor and an agonistic antibody that specifically binds CD40 for the treatment of cancer
Year of Publication 08.12.2020
Get full text
Patent
Loading…
Loading…
Co-Therapy Comprising A Small Molecule CSF-1R Inhibitor And An Agonistic Antibody That Specifically Binds CD40 For The Treatment Of Cancer
Year of Publication 05.11.2020
Get full text
Patent
Loading…
Loading…
Loading…
CO-THERAPY COMPRISING A SMALL MOLECULE CSF-1R INHIBITOR AND AN AGONISTIC ANTIBODY THAT SPECIFICALLY BINDS CD40 FOR THE TREATMENT OF CANCER
Year of Publication 02.03.2018
Get full text
Patent
Loading…
Loading…
Loading…
Genzyme Corporation issued patent titled "Colony stimulating factor-1 receptor (csf-1r) inhibitors"
Published in News Bites - Private Companies
(18.04.2023)
Get full text
Newsletter
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…